Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Mouse Mast Cell Protease-4 Deteriorates Renal Function By Contributing To Inflammation And Fibrosis In Immune Complex-Mediated Glomerulonephritis

L. Scandiuzzi, Walid Beghdadi, E. Daugas, M. Åbrink, N. Tiwari, C. Brochetta, J. Claver, N. Arouche, X. Zang, M. Pretolani, R. Monteiro, G. Pejler, U. Blank
Published 2010 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Mast cells exert protective effects in experimental antiglomerular basement membrane-induced glomerulonephritis (GN), yet the responsible mediators have not been identified. In this study, we investigated the role of mouse mast cell protease (mMCP)-4, the functional homolog of human chymase, using mMCP-4–deficient mice. Compared with wild type animals, mMCP-4–deficient mice exhibited lower proteinuria, blood creatinine, and blood urea nitrogen levels, indicating an aggravating role of mMCP-4. Kidney histology confirmed less severe renal damage in mMCP-4–deficient mice with reduced deposits, glomerular and interstitial cellularity, and fibrosis scores. High amounts of mMCP-4 were detected in renal capsules, but not in the whole kidney, from wild type mice. Its expression in renal capsules was markedly decreased after GN induction, suggesting that locally released enzyme by degranulated mast cells could contribute to the functional and physiopathological hallmarks of GN. Supporting a proinflammatory role, glomerular and interstitial macrophage and T cell infiltration, levels of proinflammatory TNF and MCP-1 mRNA, and the expression of the profibrotic peptide angiotensin II together with type I collagen were markedly downregulated in kidneys of mMCP-4−deficient mice. We conclude that mMCP-4 chymase, contrary to the global anti-inflammatory action of mast cells, aggravates GN by promoting kidney inflammation. These results highlight the complexity of mast cell-mediated inflammatory actions and suggest that chymase inhibition may represent a novel therapeutic target in GN.
This paper references
Mast cellmediated remodeling and fibrinolytic activity protect against fatal glomerulonephritis
Y. Kanamaru (2006)
10.1002/jlb.67.4.585
Chymase is a potent chemoattractant for human monocytes and neutrophils
K. Tani (2000)
10.1681/ASN.2005091013
T cells in crescentic glomerulonephritis.
P. Tipping (2006)
10.1038/sj.cdd.4402143
Reversal of renal disease: is it enough to inhibit the action of angiotensin II?
J. Dussaule (2007)
10.1111/j.1600-065X.2007.00503.x
Mast cells and inflammatory kidney disease
U. Blank (2007)
10.4049/jimmunol.180.4.2669
Inhibitory ITAM Signaling by FcαRI-FcRγ Chain Controls Multiple Activating Responses and Prevents Renal Inflammation1
Y. Kanamaru (2008)
10.1182/blood-2007-07-103309
VAMP-8 segregates mast cell-preformed mediator exocytosis from cytokine trafficking pathways.
N. Tiwari (2008)
10.1016/J.EJPHAR.2006.03.053
Mast cell chymase induces expression of chemokines for neutrophils in eosinophilic EoL-1 cells and mouse peritonitis eosinophils.
M. Terakawa (2006)
10.1097/01.ASN.0000060574.38107.3B
Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases.
Jean-Jacques Boffa (2003)
10.1172/JCI20805
Involvement of chymase-mediated angiotensin II generation in blood pressure regulation.
Ming Li (2004)
10.1038/nri2327
Immunomodulatory mast cells: negative, as well as positive, regulators of immunity
S. Galli (2008)
10.1007/978-3-642-68211-7_14
Mast cell proteases.
R. Woodbury (1981)
Suppression of anti-glomerular basement membrane nephritis by administration of anti-monocyte chemoattractant protein-1 antibody in WKY rats.
H. Fujinaka (1997)
10.1681/ASN.2008010015
Role of mast cells in progressive renal diseases.
S. Holdsworth (2008)
10.4049/jimmunol.176.9.5607
Mast Cell-Mediated Remodeling and Fibrinolytic Activity Protect against Fatal Glomerulonephritis1
Y. Kanamaru (2006)
10.1046/J.1523-1755.2001.00811.X
Mast cells find their way to the kidney.
A. Eddy (2001)
10.1016/S0014-5793(03)00864-0
Munc18‐2/syntaxin3 complexes are spatially separated from syntaxin3‐containing SNARE complexes
I. Pombo (2003)
10.1016/J.IT.2004.03.005
The ins and outs of IgE-dependent mast-cell exocytosis.
U. Blank (2004)
Involvement of chymasemediated angiotensin II generation in blood pressure regulation
M. Li (2004)
10.4049/jimmunol.0900180
Mouse Mast Cell Protease 4 Is the Major Chymase in Murine Airways and Has a Protective Role in Allergic Airway Inflammation1
I. Waern (2009)
10.1016/J.JACI.2004.07.060
The role of protease activation of inflammation in allergic respiratory diseases.
C. Reed (2004)
10.1016/s0021-9258(18)45712-2
Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart.
H. Urata (1990)
10.1291/hypres.31.1517
Evidence for Abundant Presence of Chymase-Positive Mast Cells in the Kidneys of Patients with Immunoglobulin A Nephropathy: Effect of Combination Therapy with Prednisolone and Angiotensin II Receptor Blocker Valsartan
Y. Konishi (2008)
10.1096/fj.08-120394
Mast cell chymase contributes to the antibody response and the severity of autoimmune arthritis
S. E. Magnusson (2009)
10.1681/ASN.2005080799
A pathogenetic role for mast cells in experimental crescentic glomerulonephritis.
J. Timoshanko (2006)
10.1074/JBC.273.51.33985
Physical and Functional Interaction between p72 syk and Erythropoietin Receptor*
V. Duprez (1998)
10.1146/ANNUREV.IMMUNOL.21.120601.141025
Mast cells as "tunable" effector and immunoregulatory cells: recent advances.
S. Galli (2005)
10.1002/eji.200636826
Fcα receptor I activation induces leukocyte recruitment and promotes aggravation of glomerulonephritis through the FcRγ adaptor
Y. Kanamaru (2007)
10.1172/JCI116956
Interleukin-1 receptor antagonist ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis.
W. W. Tang (1994)
Inhibitory ITAM signaling by Fc alpha RI-FcR gamma chain controls multiple activating responses and prevents renal inflammation.
Y. Kanamaru (2008)
10.1007/BF00197505
Mast cells
J. Marshall (1990)
10.1007/s11010-006-9342-0
Chymase increases glomerular albumin permeability via protease-activated receptor-2
R. Sharma (2006)
10.1038/ni1503
Mast cell–derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B
M. Grimbaldeston (2007)
10.1046/j.1365-2613.1998.00080.x
Failure to induce anti‐glomerular basement membrane glomerulonephritis in TNFα/β deficient mice
B. Ryffel (1998)
10.1046/J.1523-1755.1998.00108.X
Distinct contribution of Fc receptors and angiotensin II-dependent pathways in anti-GBM glomerulonephritis.
Y. Suzuki (1998)
10.1016/S0167-4838(00)00076-5
Angiotensin II generation by mast cell α- and β-chymases
G. Caughey (2000)
Impaired integrin-mediated signal transduction, altered cytoskeletal structure and reduced motility in Hck/Fgr deficient macrophages.
P. W. Suen (1999)
10.1159/000007499
Role of Endothelins
A. Gerbes (1998)
10.1172/JCI19062
Mast cell dipeptidyl peptidase I mediates survival from sepsis.
J. Mallen-St. Clair (2004)
10.1161/CIRCULATIONAHA.109.849679
Critical Role of Mast Cell Chymase in Mouse Abdominal Aortic Aneurysm Formation
J. Sun (2009)
10.1038/nm1738
Neurotensin increases mortality and mast cells reduce neurotensin levels in a mouse model of sepsis
A. Piliponsky (2008)
Fc alpha receptor I activation induces leukocyte recruitment and promotes aggravation of glomerulonephritis through the FcR gamma adaptor.
Y. Kanamaru (2007)
10.1111/j.1600-065X.2007.00525.x
Protease–proteoglycan complexes of mouse and human mast cells and importance of their β‐tryptase–heparin complexes in inflammation and innate immunity
R. Stevens (2007)
10.1074/JBC.M410396200
A Key Role for Mast Cell Chymase in the Activation of Pro-matrix Metalloprotease-9 and Pro-matrix Metalloprotease-2*
E. Tchougounova (2005)
10.1097/01.ASN.0000109782.28991.26
Chymase-like angiotensin II-generating activity in end-stage human autosomal dominant polycystic kidney disease.
E. A. Mcpherson (2004)
10.1038/nature05010
Mast cells are essential intermediaries in regulatory T-cell tolerance
L. Lu (2006)
Isolated glomerular basement membrane as antigen in indirect immunofluorescent test for identification of circulating rabbit anti-rat glomerular-basement membrane antibodies.
D. D. de Almeida (1971)
10.1016/J.SEMNEPHROL.2007.02.002
Cytokines in glomerulonephritis.
P. Tipping (2007)
Failure to induce anti-glomerular basement membrane glomerulonephritis in TNF alpha/beta deficient mice.
B. Ryffel (1998)
10.1124/pr.59.3.3
The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease
H. Kobori (2007)
10.1172/JCI2132
Nitric oxide inhibition induces early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice. Role of endothelin.
C. Chatziantoniou (1998)
10.1073/pnas.0906372106
Mast cells regulate homeostatic intestinal epithelial migration and barrier function by a chymase/Mcpt4-dependent mechanism
K. Groschwitz (2009)
Angiotensin II generation by mast cell alpha- and beta-chymases.
G. Caughey (2000)
10.1074/JBC.M405576200
Cooperation between Mast Cell Carboxypeptidase A and the Chymase Mouse Mast Cell Protease 4 in the Formation and Degradation of Angiotensin II*
A. Lundequist (2004)
10.1111/j.1600-065X.2007.00509.x
Mast cell tryptases and chymases in inflammation and host defense
G. Caughey (2007)
10.1084/JEM.194.1.F1
The Diverse Roles of Mast Cells
M. Gurish (2001)
10.1084/jem.20030671
The Chymase, Mouse Mast Cell Protease 4, Constitutes the Major Chymotrypsin-like Activity in Peritoneum and Ear Tissue. A Role for Mouse Mast Cell Protease 4 in Thrombin Regulation and Fibronectin Turnover
E. Tchougounova (2003)
10.1007/s00011-007-6145-z
Possible involvement of mast cells in renal fibrosis in patients with IgA nephropathy
T. Sakamoto-Ihara (2007)
10.1097/01.ASN.0000071512.93927.4E
Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease.
X. Huang (2003)
10.1002/eji.200526250
Role of mast cells in experimental anti‐glomerular basement membrane glomerulonephritis
K. Hochegger (2005)
10.1126/SCIENCE.1128877
Mast Cells Can Enhance Resistance to Snake and Honeybee Venoms
M. Metz (2006)
10.1042/BJ20061257
Serglycin proteoglycan is required for secretory granule integrity in mucosal mast cells.
Tiago Braga (2007)



This paper is referenced by
10.1155/2016/9797021
Significant Contribution of Mouse Mast Cell Protease 4 in Early Phases of Experimental Autoimmune Encephalomyelitis
L. Desbiens (2016)
10.1016/j.toxlet.2016.08.007
Tributyltin chloride induces renal dysfunction by inflammation and oxidative stress in female rats.
João V.S. Coutinho (2016)
10.1007/978-3-0348-0157-7_7
Proteases and Fibrosis
M. Heightman (2011)
10.1111/j.1476-5381.2012.02055.x
Chymase inhibition as a pharmacological target: a role in inflammatory and functional gastrointestinal disorders?
S. Heuston (2012)
10.1016/j.molimm.2019.07.024
Giardia excretory-secretory proteins modulate the enzymatic activities of mast cell chymase and tryptase.
Zhiqiang Li (2019)
Renal Interstitial Fibrosis: Mechanisms and Evaluation In: Current Opinion in Nephrology and Hypertension
A. Farris ()
Enhanced vascular chymase-dependent conversion of endothelin in the diabetic kidney.
L. Harrison-Bernard (2013)
hrough a Chymase/Mast Cell Protease 4 Lung Inflammation and Injury in Mice t Mast Cells Contribute to Bleomycin-Induced
Nelly Frossard (2014)
10.1681/ASN.2014090906
Mast Cell Stabilization Ameliorates Autoimmune Anti-Myeloperoxidase Glomerulonephritis.
P. Gan (2016)
10.1016/j.bcp.2015.02.001
Chymase inhibitor-sensitive synthesis of endothelin-1 (1-31) by recombinant mouse mast cell protease 4 and human chymase.
W. Semaan (2015)
Identification of Bromodomain-Containing Protein 4 (BRD4) as a Novel Marker and Epigenetic Target in Systemic Mastocytosis and Mast Cell Leukemia
Ghaith Wedeh (2016)
10.1016/j.molimm.2014.03.002
Mast cells in renal inflammation and fibrosis: lessons learnt from animal studies.
L. C. Madjene (2015)
10.3390/ijms21207495
Mechanism of Albuminuria Reduction by Chymase Inhibition in Diabetic Mice
Kentaro Terai (2020)
Mast cell activation and degranulation promotes renal fibrosis in experimental unilateral ureteric
A. Summers (2012)
10.1007/978-1-4939-1568-2_29
The function of mast cells in autoimmune glomerulonephritis.
R. Monteiro (2015)
10.14814/phy2.14302
Chymase inhibition retards albuminuria in type 2 diabetes
Benjamin J. Bivona (2019)
10.1038/nrneph.2014.180
Immune cells in experimental acute kidney injury
H. R. Jang (2015)
10.18632/oncotarget.15339
The combined action of mast cell chymase, tryptase and carboxypeptidase A3 protects against melanoma colonization of the lung
M. Grujić (2017)
10.1007/978-981-13-8871-2_18
Inflammatory Mediators and Renal Fibrosis.
Xiao-ming Meng (2019)
10.1371/journal.pone.0167964
Increased Bone Mass in Female Mice Lacking Mast Cell Chymase
T. Lind (2016)
10.3389/fimmu.2017.00450
Mast Cells and MCPT4 Chymase Promote Renal Impairment after Partial Ureteral Obstruction
M. Pons (2017)
10.1007/978-1-4419-9533-9_11
Mast cells and immunoregulation/immunomodulation.
M. Tsai (2011)
10.1007/978-3-319-47385-7_6
Immunopathology of the Urinary System
C. Picut (2017)
10.1007/s00018-010-0587-0
Biological implications of preformed mast cell mediators
A. Lundequist (2010)
10.1074/jbc.M111.272401
Dual Targets for Mouse Mast Cell Protease-4 in Mediating Tissue Damage in Experimental Bullous Pemphigoid*
L. Lin (2011)
10.1155/2015/142359
The Role of Mast Cell Specific Chymases and Tryptases in Tumor Angiogenesis
D. A. de Souza Júnior (2015)
10.1111/imr.12626
The controversial role of mast cells in fibrosis
P. Bradding (2018)
10.1681/ASN.2011020182
Mast cells mediate acute kidney injury through the production of TNF.
S. Summers (2011)
10.1038/ki.2012.211
Mast cell activation and degranulation promotes renal fibrosis in experimental unilateral ureteric obstruction.
S. Summers (2012)
10.3389/fimmu.2011.00037
Mast Cells as Cellular Sensors in Inflammation and Immunity
Walid Beghdadi (2011)
10.1152/ajprenal.00706.2011
Effect of a serine protease inhibitor on the progression of chronic renal failure.
M. Hayata (2012)
10.4049/jimmunol.1300875
Mast Cells Contribute to Bleomycin-Induced Lung Inflammation and Injury in Mice through a Chymase/Mast Cell Protease 4–Dependent Mechanism
L. Reber (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar